{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:05:09Z","timestamp":1748869509798,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072653","81602035"],"award-info":[{"award-number":["82072653","81602035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation","doi-asserted-by":"publisher","award":["81472228"],"award-info":[{"award-number":["81472228"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010032","name":"Health and Family Planning Commission of Sichuan Province","doi-asserted-by":"publisher","award":["Q2017-059"],"award-info":[{"award-number":["Q2017-059"]}],"id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Science and Technology Innovation Project of Shanghai","award":["SHDC12016104"],"award-info":[{"award-number":["SHDC12016104"]}]},{"name":"Shanghai Engineering Research Center of Colorectal Cancer Minimally Invasive","award":["17DZ2252600"],"award-info":[{"award-number":["17DZ2252600"]}]},{"name":"Youth fund of Zhongshan Hospital","award":["2019ZSQN28"],"award-info":[{"award-number":["2019ZSQN28"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-022-09063-0","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T10:04:11Z","timestamp":1662458651000},"page":"1022-1030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Preoperative transarterial chemoembolization with drug-eluting beads (DEB-TACE) in patients undergoing conversional hepatectomy: a propensity-score matching analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenju","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5441-8240","authenticated-orcid":false,"given":"Jianmin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"9063_CR1","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","DOI":"10.3322\/caac.21492"},{"key":"9063_CR2","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/ijc.28443","volume":"134","author":"T Gruber-Rouh","year":"2014","unstructured":"Gruber-Rouh T, Naguib NN, Eichler K et al (2014) Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Int J Cancer 134:1225\u20131231","journal-title":"Int J Cancer"},{"issue":"Suppl 5","key":"9063_CR3","doi-asserted-by":"publisher","first-page":"v93","DOI":"10.1093\/annonc\/mdq222","volume":"21","author":"E Van Cutsem","year":"2010","unstructured":"Van Cutsem E, Nordlinger B, Cervantes A (2010) Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. Ann Oncol 21(Suppl 5):v93\u2013v97","journal-title":"Ann Oncol"},{"issue":"Suppl 2","key":"9063_CR4","doi-asserted-by":"publisher","first-page":"ii13","DOI":"10.1093\/annonc\/mdg731","volume":"14","author":"R Adam","year":"2003","unstructured":"Adam R (2003) Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 14(Suppl 2):ii13\u2013ii16","journal-title":"Ann Oncol"},{"issue":"Suppl 2","key":"9063_CR5","doi-asserted-by":"publisher","first-page":"S242","DOI":"10.1245\/s10434-015-4460-0","volume":"23","author":"Y Maeda","year":"2016","unstructured":"Maeda Y, Shinohara T, Nagatsu A, Futakawa N, Hamada T (2016) Long-term outcomes of conversion hepatectomy for initially unresectable colorectal liver metastases. Ann Surg Oncol 23(Suppl 2):S242\u2013S248","journal-title":"Ann Surg Oncol"},{"key":"9063_CR6","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/annonc\/mdu088","volume":"25","author":"G Folprecht","year":"2014","unstructured":"Folprecht G, Gruenberger T, Bechstein W et al (2014) Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX\/cetuximab or FOLFIRI\/cetuximab in a multidisciplinary concept (CELIM study). Ann Oncol 25:1018\u20131025","journal-title":"Ann Oncol"},{"key":"9063_CR7","doi-asserted-by":"crossref","unstructured":"de Jong MC, Pulitano C, Ribero D et al (2009) Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250:440\u2013448","DOI":"10.1097\/SLA.0b013e3181b4539b"},{"key":"9063_CR8","doi-asserted-by":"crossref","unstructured":"Mitry E, Fields AL, Bleiberg H et al (2008) Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 26:4906\u20134911","DOI":"10.1200\/JCO.2008.17.3781"},{"key":"9063_CR9","doi-asserted-by":"crossref","unstructured":"Nordlinger B, Sorbye H, Glimelius B et al (2013) Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 14:1208\u20131215","DOI":"10.1016\/S1470-2045(13)70447-9"},{"key":"9063_CR10","doi-asserted-by":"crossref","unstructured":"Lorenz M, M\u00fcller HH, Schramm H et al (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 228:756\u2013762","DOI":"10.1097\/00000658-199812000-00006"},{"key":"9063_CR11","doi-asserted-by":"crossref","unstructured":"Kemeny MM, Adak S, Gray B et al (2002) Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study. J Clin Oncol 20:1499\u20131505","DOI":"10.1200\/JCO.20.6.1499"},{"key":"9063_CR12","doi-asserted-by":"crossref","unstructured":"Fielding LP, Hittinger R, Grace RH, Fry JS (1992) Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma. Lancet 340:502\u2013506","DOI":"10.1016\/0140-6736(92)91708-G"},{"key":"9063_CR13","doi-asserted-by":"crossref","unstructured":"Liu Y, Chang W, Zhou B et al (2021) Conventional transarterial chemoembolization combined with systemic therapy versus systemic therapy alone as second-line treatment for unresectable colorectal liver metastases: randomized clinical trial. Br J Surg 108:373\u2013379","DOI":"10.1093\/bjs\/znaa155"},{"key":"9063_CR14","doi-asserted-by":"crossref","unstructured":"Melchiorre F, Patella F, Pescatori L et al (2018) DEB-TACE: a standard review. Future Oncol 14:2969\u20132984","DOI":"10.2217\/fon-2018-0136"},{"key":"9063_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00270-013-0632-0","volume":"37","author":"P Huppert","year":"2014","unstructured":"Huppert P, Wenzel T, Wietholtz H (2014) Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population. Cardiovasc Intervent Radiol 37:154\u2013164","journal-title":"Cardiovasc Intervent Radiol"},{"key":"9063_CR16","doi-asserted-by":"crossref","unstructured":"Ngo A, von Stempel C, Corbo B et al (2019) Transarterial chemoembolisation of colorectal liver metastases with irinotecan-loaded beads: a bi-institutional analysis of 125 treatments in 53 patients. Cardiovasc Intervent Radiol 42:979\u2013990","DOI":"10.1007\/s00270-019-02219-4"},{"key":"9063_CR17","doi-asserted-by":"crossref","unstructured":"Lv Y, Feng QY, Wei Y et al (2020) Benefits of multi-disciplinary treatment strategy on survival of patients with colorectal cancer liver metastasis. Clin Transl Med 10:e121","DOI":"10.1002\/ctm2.121"},{"key":"9063_CR18","doi-asserted-by":"crossref","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216","DOI":"10.1093\/jnci\/92.3.205"},{"key":"9063_CR19","doi-asserted-by":"crossref","unstructured":"Tang W, Ren L, Liu T et al (2020) Bevacizumab plus mFOLFOX6 versus mFOLFOX6 alone as first-line treatment for RAS mutant unresectable colorectal liver-limited metastases: the BECOME Randomized Controlled Trial. J Clin Oncol 38:3175\u20133184","DOI":"10.1200\/JCO.20.00174"},{"key":"9063_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309\u2013318 discussion 318-21","journal-title":"Ann Surg"},{"key":"9063_CR21","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1245\/s10434-018-6462-1","volume":"25","author":"MR Weiser","year":"2018","unstructured":"Weiser MR (2018) AJCC 8th Edition: Colorectal Cancer. Ann Surg Oncol 25:1454\u20131455","journal-title":"Ann Surg Oncol"},{"key":"9063_CR22","doi-asserted-by":"crossref","unstructured":"Hamashige S, Arquilla ER (2008) Common Terminology Criteria for Adverse Events v3.0 (CTCAE). Principles and Practice of Clinical Trial Medicine vol 42, pp 461\u2013533","DOI":"10.1016\/B978-0-12-373695-6.00022-3"},{"key":"9063_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"key":"9063_CR24","doi-asserted-by":"crossref","unstructured":"Martin RC, Joshi J, Robbins K et al (2011) Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study. Ann Surg Oncol 18:192\u2013198","DOI":"10.1245\/s10434-010-1288-5"},{"key":"9063_CR25","doi-asserted-by":"crossref","unstructured":"Pernot S, Pellerin O, Artru P et al (2020) Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a phase 2 study. Br J Cancer 123:518\u2013524","DOI":"10.1038\/s41416-020-0917-4"},{"key":"9063_CR26","doi-asserted-by":"crossref","unstructured":"Martin RC 2nd, Scoggins CR, Schreeder M et al (2015) Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis. Cancer 121:3649\u20133658","DOI":"10.1002\/cncr.29534"},{"key":"9063_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.suronc.2017.05.003","volume":"26","author":"O Akinwande","year":"2017","unstructured":"Akinwande O, Dendy M, Ludwig JM, Kim HS (2017) Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: a systematic review. Surg Oncol 26:268\u2013275","journal-title":"Surg Oncol"},{"key":"9063_CR28","doi-asserted-by":"crossref","unstructured":"Zhao G, Liu S, Zhang Y et al (2021) Irinotecan eluting beads-transarterial chemoembolization using Callispheres\u00ae microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases. Ir J Med Sci 191:1139\u20131145","DOI":"10.1007\/s11845-021-02629-9"},{"key":"9063_CR29","doi-asserted-by":"crossref","unstructured":"Fiorentini G, Sarti D, Nani R, Aliberti C, Fiorentini C, Guadagni S (2020) Updates of colorectal cancer liver metastases therapy: review on DEBIRI. Hepat Oncol 7:Hep16","DOI":"10.2217\/hep-2019-0010"},{"key":"9063_CR30","doi-asserted-by":"crossref","unstructured":"Ye L-C, Liu T-S, Ren L et al (2013) Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. J Clin Oncol 31:1931\u20131938","DOI":"10.1200\/JCO.2012.44.8308"},{"key":"9063_CR31","doi-asserted-by":"crossref","unstructured":"Liu M, Wang K, Wang Y et al (2021) Short- and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for patients with multiple primarily unresectable colorectal liver metastases: a propensity matching analysis. HPB (Oxford) 23:1586\u20131594","DOI":"10.1016\/j.hpb.2021.03.014"},{"key":"9063_CR32","doi-asserted-by":"crossref","unstructured":"van Amerongen MJ, van der Stok EP, F\u00fctterer JJ et al (2016) Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation. Eur J Surg Oncol 42:523\u2013530","DOI":"10.1016\/j.ejso.2016.01.013"},{"key":"9063_CR33","doi-asserted-by":"crossref","unstructured":"Conci S, Ruzzenente A, Pedrazzani C et al (2021) Simultaneous approach for patients with synchronous colon and rectal liver metastases: impact of site of primary on postoperative and oncological outcomes. Eur J Surg Oncol 47:842\u2013849","DOI":"10.1016\/j.ejso.2020.09.015"},{"key":"9063_CR34","doi-asserted-by":"crossref","unstructured":"Bogach J, Wang J, Griffiths C et al (2020) Simultaneous versus staged resection for synchronous colorectal liver metastases: a population-based cohort study. Int J Surg 74:68\u201375","DOI":"10.1016\/j.ijsu.2019.12.009"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-09063-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-022-09063-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-09063-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T09:20:27Z","timestamp":1675156827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-022-09063-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["9063"],"URL":"https:\/\/doi.org\/10.1007\/s00330-022-09063-0","relation":{},"ISSN":["1432-1084"],"issn-type":[{"type":"electronic","value":"1432-1084"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"12 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Jianmin Xu.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Donghao Xu (one of the authors) kindly provided statistical advice for this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}